Clinical and biological predictors of long-term course of major depressive disorder
重度抑郁症长期病程的临床与生物预测因子
Early change in emotional processing as a predictor of treatment outcome with antidepressants or psychotherapy
情绪加工的早期改变是抗抑郁药或心理治疗结局的一个预测因子
fMRI markers for the prediction of short- and long-term outcome in major depressive disorder
功能性磁共振成像标记应用于重度抑郁症诊断和预后
IMI: Opportunities for researchers from IMI to Horizon 2020
创新药物计划：从IMI到展望2020对研究者的机遇
EU-AIMS: An European initiative with global impact on autism research
EU-AIMS：欧洲一项具有全球影响力的自闭症研究倡议
NewMeds: data sharing and new medications for depression and schizophrenia
NewMeds项目: 抑郁症和精神分裂症的数据共享和新药治疗方案
Dysfunctional GABAergic networks in psychiatric disorders
GABA能缺陷的功能性结果：海马网络中抑制和振荡模式的改变
Modulation of GABA-A receptor function for the treatment of anxiety disorders
γ-氨基丁酸(GABA) A受体功能的调节在焦虑症治疗中的作用
GABAergic dysfunctions in animal models for mood disorders
动物心境障碍模型中γ-氨基丁酸能的功能障碍
Topographically organised serotonergic systems in the dorsal raphe play diverse roles in anxiety and depression
中缝背核中以局部区域组成的5-羟色胺系统在焦虑症和抑郁症中起不同的作用
Dopamine neuron subgroups in the dorsal raphe and ventral tegmental area exhibit distinct synaptic adaptations in response to social isolation and drugs of abuse
中缝背核和腹侧被盖区的多巴胺能神经元亚群由于社交隔离和药物滥用呈现明显的突触可塑现象
Subgroups of midbrain dopamine neurons exhibit discrete expression of endocannabinoid-mediated plasticity
中脑多巴胺能神经元表达不同的大麻素介导的神经可塑性
Anxiety And Social dominance
焦虑症和社会等级中的主导地位
Factors explaining suicidal behaviour and mortality in alcohol dependence
酒精依赖中自杀行为和死亡率的影响因素
Alcohol and suicidal risk: the epigenetic insight
酒精和自杀风险与表观遗传学的关系见解
Epigenetics as a potential mechanism for intervention
精神疾病的表观基因组学：从病因到治疗干预
Translational paediatric pharmacology
儿科转化精神药理学
Paediatric clinical trials: methodological issues and problems
儿科临床试验：方法论上的问题和难题
Should we expect smaller effect sizes in paediatric clinical trials?
儿科临床试验能否期待较小的疗效指数？
Pragmatic outcome assessment in clinical trials with children
儿童临床试验中的实用性转归指标
Low-dose and time-limited antipsychotic treatment strategies in schizophrenia
精神分裂症的低剂量和有限疗程治疗策略
Glutamatergic agents for the treatment of schizophrenia
谷氨酸能药物治疗精神分裂症
Nicotine receptor agonist treatment in schizophrenia
尼古丁受体激动剂在精神分裂症治疗中的作用
Inflammatory markers in bipolar spectrum disorders
双相情感障碍的炎症标志物
Neurotrophins, brain interconnectivity and neuronal survival in bipolar disorder
神经营养因子、大脑连接以及神经元存活在双相情感障碍症中的作用
Neuroimaging deviations in bipolar disorder: genetic liability and structural disconnectivity
双相情感障碍中的神经影像学偏离：遗传倾向和结构不连续
Stress and adult hippocampal neurogenesis
应激与成年海马神经再生
Innovative tools for 'proof-of-pharmacological-concept' studies
“药理学概念证明”研究的创新性工具
Making better early go/no-go decisions in drug development progress in the NIMH FAST-FAIL programme
药物研发中应更早做出继续或终止的决定
